London
· Delayed Price · Currency is GBP · Price in GBX AIM: CNSL Statistics
Total Valuation
Cambridge Nutritional Sciences has a market cap or net worth of GBP 8.80 million. The enterprise value is 4.36 million.
| Market Cap | 8.80M |
| Enterprise Value | 4.36M |
Important Dates
The next estimated earnings date is Thursday, February 20, 2025.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cambridge Nutritional Sciences has 237.95 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 237.95M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 55.69% |
| Float | 232.26M |
Valuation Ratios
The trailing PE ratio is 50.62.
| PE Ratio | 50.62 |
| Forward PE | n/a |
| PS Ratio | 0.98 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 1.46 |
| P/FCF Ratio | 19.96 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 207.77, with an EV/FCF ratio of 9.89.
| EV / Earnings | 25.08 |
| EV / Sales | 0.49 |
| EV / EBITDA | 207.77 |
| EV / EBIT | n/a |
| EV / FCF | 9.89 |
Financial Position
The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.13 |
| Quick Ratio | 4.60 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | 0.18 |
| Interest Coverage | -15.53 |
Financial Efficiency
Return on equity (ROE) is 1.85% and return on invested capital (ROIC) is -1.93%.
| Return on Equity (ROE) | 1.85% |
| Return on Assets (ROA) | -1.35% |
| Return on Capital (ROIC) | -1.93% |
| Revenue Per Employee | 95,468 |
| Profits Per Employee | 1,851 |
| Employee Count | 94 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.47% in the last 52 weeks. The beta is 3.93, so Cambridge Nutritional Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 3.93 |
| 52-Week Price Change | +46.47% |
| 50-Day Moving Average | 3.14 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 59.49 |
| Average Volume (20 Days) | 646,007 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cambridge Nutritional Sciences had revenue of GBP 8.97 million and earned 174,000 in profits. Earnings per share was 0.00.
| Revenue | 8.97M |
| Gross Profit | 5.66M |
| Operating Income | -295,000 |
| Pretax Income | -243,000 |
| Net Income | 174,000 |
| EBITDA | -80,000 |
| EBIT | -295,000 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 4.52 million in cash and 79,000 in debt, giving a net cash position of 4.44 million or 0.02 per share.
| Cash & Cash Equivalents | 4.52M |
| Total Debt | 79,000 |
| Net Cash | 4.44M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 9.54M |
| Book Value Per Share | 0.04 |
| Working Capital | 6.04M |
Cash Flow
In the last 12 months, operating cash flow was 616,000 and capital expenditures -175,000, giving a free cash flow of 441,000.
| Operating Cash Flow | 616,000 |
| Capital Expenditures | -175,000 |
| Free Cash Flow | 441,000 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 63.02%, with operating and profit margins of -3.29% and 1.94%.
| Gross Margin | 63.02% |
| Operating Margin | -3.29% |
| Pretax Margin | -2.71% |
| Profit Margin | 1.94% |
| EBITDA Margin | -0.89% |
| EBIT Margin | -3.29% |
| FCF Margin | 4.91% |
Dividends & Yields
Cambridge Nutritional Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.36% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 31, 2007. It was a reverse split with a ratio of 0.025.
| Last Split Date | Aug 31, 2007 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
Cambridge Nutritional Sciences has an Altman Z-Score of -0.41. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.41 |
| Piotroski F-Score | n/a |